Cheryl B. Iglesia, MD

Author:

Cheryl B. Iglesia, MD

The authors review adverse outcomes of tubal occlusion devices and data on how and when to remove them

The eval...

• Read More

Author:

Cheryl B. Iglesia, MD

No. According to a randomized controlled trial in which 78 postmenopausal women with bothersome vaginal symptoms received either v...

• Read More

Author:

Cheryl B. Iglesia, MD

Laser and radiofrequency devices are “out there” as therapeutic options for gyn cosmetic conditions, and some studies...

• Read More

Author:

Cheryl B. Iglesia, MD

There are not enough data to recommend laser therapy over the gold standard, transvaginal estrogen, for treating symptoms of the g...

• Read More

Author:

Cheryl B. Iglesia, MD

Maybe, but we need more data. There was a significant difference in surgeon satisfaction with the use of mannitol as a bladder distention medium du...

• Read More

Author:

Cheryl B. Iglesia, MD

Brought to you by the Society of Gynecologic Surgeons.
In a recent expansion of laser technology, dozens of manufacturers have ...

• Read More

Author:

Cheryl B. Iglesia, MD

The USPSTF says there is not enough evidence to assess the benefits and harms of the routine screening pelvic exam. These experts say that ObGyns s...

• Read More

Author:

Cheryl B. Iglesia, MD

How do we get past the current “chill” on innovation in gynecologic surgery?

• Read More

Author:

Cheryl B. Iglesia, MD

A patient may skip talking about sexual function out of embarrassment, and a clinician out of concern for the patient’s feelings. We may be overloo...

• Read More

Author:

Cheryl B. Iglesia, MD

The ObGyn specialty is moving into a data-driven future for pelvic organ prolapse surgery

• Read More

Author:

Cheryl B. Iglesia, MD

• Read More